Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme

Susan M. Chang*, Patrick Wen, Timothy Cloughesy, Harry Greenberg, David Schiff, Charles Conrad, Karen Fink, H. Ian Robins, Lisa De Angelis, Jeffrey Raizer, Kenneth Hess, Ken Aldape, Kathleen R. Lamborn, John Kuhn, Janet Dancey, Michael D. Prados

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

383 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science